UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM6-K
Report of Foreign Private Issuer
Pursuant to Rule13a-16 or15d-16
of the Securities Exchange Act of 1934
Date of Report: June 29, 2018
Commission File Number:001-36891
Cellectis S.A.
(Exact Name of registrant as specified in its charter)
8, rue de la Croix Jarry
75013 Paris, France
+33 1 81 69 16 00
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form20-F or Form40-F:
Form20-F ☒ Form40-F ☐
Indicate by check mark if the registrant is submitting the Form6-K in paper as permitted by RegulationS-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form6-K in paper as permitted by RegulationS-T Rule 101(b)(7): ☐
Cellectis S.A. (the “Company”) previously reported, in connection with its Combined Ordinary and Extraordinary Meeting (the “Meeting”) on June 26, 2018, that certain amendments to the Company’s Bylaws were adopted. Filed as Exhibit 99.1 hereto are Bylaws of the Company, updated as of June 26, 2018, restated to incorporate such previously adopted and reported amendments.
This report on Form6-K shall be deemed to be incorporated by reference in the Company’s registration statements on FormF-3(333-217086), FormS-8(333-204205), FormS-8(333-214884) and FormS-8(333-222482), in each case to the extent not superseded by documents or reports subsequently filed.
EXHIBIT INDEX
| | |
Exhibit | | Title |
| |
| 99.1 | | Bylaws (statuts) of the registrant as of June 26, 2018 (English Translation). |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| | | | | | |
| | | | CELLECTIS S.A. (Registrant) |
| | | |
| June 29, 2018 | | | | By: | | /s/ André Choulika |
| | | | | | André Choulika |
| | | | | | Chief Executive Officer |
